Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.

× No keyword cloud information.

22 in total

1. Schizophrenia and severe tardive dyskinesia responsive to risperidone.

Authors: L C Kopala; W G Honer
Journal: J Clin Psychopharmacol Date: 1994-12 Impact factor: 3.153

Review 2. Serotonin and anxiety revisited.

Authors: R S Kahn; H M van Praag; S Wetzler; G M Asnis; G Barr
Journal: Biol Psychiatry Date: 1988-01-15 Impact factor: 13.382

3. Sertraline treatment of aggression in a developmentally disabled patient.

Authors: J J Campbell; J D Duffy
Journal: J Clin Psychiatry Date: 1995-03 Impact factor: 4.384

Review 4. Tardive dyskinesia.

Authors: D V Jeste; M P Caligiuri
Journal: Schizophr Bull Date: 1993 Impact factor: 9.306

5. Behaviour symptoms among severely and profoundly mentally retarded patients. A 16-18 year follow-up study.

Authors: A H Reid; B R Ballinger
Journal: Br J Psychiatry Date: 1995-10 Impact factor: 9.319

6. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.

Authors: R Cavallaro; M G Regazzetti; E Mundo; V Brancato; E Smeraldi
Journal: Neuropsychopharmacology Date: 1993-05 Impact factor: 7.853

7. Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment.

Authors: P Dalgalarrondo; W F Gattaz
Journal: Eur Arch Psychiatry Clin Neurosci Date: 1994 Impact factor: 5.270

8. Ten-year outcome of tardive dyskinesia.

Authors: G Gardos; D E Casey; J O Cole; A Perenyi; E Kocsis; M Arato; J A Samson; C Conley
Journal: Am J Psychiatry Date: 1994-06 Impact factor: 18.112

9. Risperidone in the treatment of schizophrenia.

Authors: S R Marder; R C Meibach
Journal: Am J Psychiatry Date: 1994-06 Impact factor: 18.112

10. Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study.

Authors: G Chouinard
Journal: J Clin Psychopharmacol Date: 1995-02 Impact factor: 3.153

5 in total

1. Use of functional analysis methodology in the evaluation of medication effects.

Authors: Kimberly A Crosland; Jennifer R Zarcone; Steven E Lindauer; Maria G Valdovinos; Troy J Zarcone; Jessica A Hellings; Stephen R Schroeder
Journal: J Autism Dev Disord Date: 2003-06

2. Risperidone treatment in 12 children with developmental disorders and attention-deficit/hyperactivity disorder.

Authors: Valsamma Eapen; A K Gururaj
Journal: Prim Care Companion J Clin Psychiatry Date: 2005

Review 3. Risperidone. A pharmacoeconomic review of its use in schizophrenia.

Authors: R H Foster; K L Goa
Journal: Pharmacoeconomics Date: 1998-07 Impact factor: 4.981

Review 4. Effects of newer antipsychotics on extrapyramidal function.

Authors: Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal: CNS Drugs Date: 2002 Impact factor: 5.749

Review 5. Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities.

Authors: R Antochi; C Stavrakaki; P C Emery
Journal: Postgrad Med J Date: 2003-03 Impact factor: 2.401

5 in total